We would love to hear your thoughts about our site and services, please take our survey here.
In the end whichever company is chosen to help save people's lives wether CIZ or any other organization does not matter as long as a rational and ethical decision is made based in the efficacy of the product.... which in my opinion should be CIZ as this product has been developing for decades already... Let wait for further announcements and I hope CIZ can get some sort of sponsorship or promotion...
I believe CIZ should focus in the FDA approval and the USA market. The reality is that the NHS is a corrupt organization and so it is most pharmaceuticals and goverments.... Grail is still on very early trials phase and in comparison we have a far more developed product that we know it works and in my opinion if the NHS decides to use another product instead of ours just because the sponsorship and the money of Bezos then the system is well f ck u p, and companies like the NHS are just playing with the lives of people. But at this stage and and the world we currently live in I will not be surprised.... as it is all about frienships and connections .....
In my opinion I see GCAT reaching that 2k gold oz /month target at Q1/Q2 2023. The reason for this is that they are still quite behind to catch to this number due to several plant upgrades. Q2 report will give an idea of that, but I dont expect magic numbers. Of course, I might be wrong and the heap leach plant potential and some high average grade numbers during the quarter may see us hit that 2k oz in Q4 2022. Either way this company is really undervalued based on current numbers or future numbers. What is more, we are gonna enter a rich news period, and with some good sentiment and rising gold price who knows.... the SP might rise to 2p or 3p this year alone???
A lot more than what some traders here are arguing ( "2 pence)". I have read that people are valuing GCAT based only in the gold production of 24k oz gold pa. of Kilimapesa by year end or early 2023. But they are not taking into account the acquisitions of the projects of Nyakafuru which contains 700k of gold oz, and Simba which contains 320k oz of gold resources. Thats over 1 million oz of gold on top of recent upgrade of jorc resources of Kilimapesa, totalling 2.3 million oz of gold. Im pretty sure those two projects gotta have some value. On top of that there are many other things such as a self funding exploration campaign as we have 2 drilling rigs, an amazing BOD, heap leach plant potential, etc...
So it is hard to determine the "true value" but in my opinion 5p is very achievable within 6-12 months
Every day that passes we are more and more undervalued....
1.3million gold oz right now including both projects
Then after drill results and maiden resource this year at kilimapesa we will be at 3.3million gold oz
And we are sitting at £12m mcap O.O shocking IMO
Plus we are producing gold and we own 2 drilling rigs
Plus by year end 2k oz of gold production rate, which means next year we will producing 24k oz of gold per annum (44$ million revenue)
And we sitting at £12m mcap!!!!
Potential is here to multibag. For me is about patience I have a feeling rhis will turn good in the future. Obviously those from the ipo wo bought at 10p must be very angry, but if the cancer test commercial deal with china and us turns good we will see 10p and beyond for sure IMO.
And everyone is saying is the seller "fault".....
We have been going like this for months!!!
For every seller there should be a buyer if a company is performing good and has good prospects!! That is not the case here......
So there is a manipulation going on??
Shocking IMO
I am following (not invested) several junior explorers in LSE and AIM, and they have the same or more MCAP than GCAT, and they have 0 sources of finance except Equity dilution and 0 Revenues, and yet as I said they are about the same mcap as GCAT or higher, and they dont have yet proven reserves. We have prove reserves, we are producing gold and we have revenues, we have our own drilling rigs and an amazing BOD.
I Just dont understand.....
Many companies out there, one example is MILA, no proven reserves no revenue not owned drilling rigs and yet the have more MCAP than us!!!
UNVELIEBABLE!!!!
The Market is on Shambles!!!
And the sector is overalll terribly valued with rising gold price!!!!!
For starters break-even for me, and that means 3p. I feel sorry for shareholders that bought at 10p at the ipo and have been holding since then. Whatever people say, it is responsability of company to create shareholder value as means of SP and not promises and rainbows. So far Cizzle Biotech has done nothing positive when creating shareholder value